News, Analysis & Insights on Nutrition, Supplements, and Health
Over 90% of African Americans may have vitamin D deficiency, and daily doses of 4,000IU may be needed to eliminate deficiency, says a new study from the Medical University of South Carolina.
Secret wartime papers have been uncovered that detail a Nazi plot to plant exploding chocolate in the British War Cabinet dining room in a bid to kill former Prime Minister Sir Winston Churchill, according to reports.
On the eve of the Olympics, Oxford University academics writing in the British Medical Journal – in conjunction with the BBC Panorama documentary team – have damned sports nutrition products like GlaxoSmithKline’s Lucozade Sport for lacking scientific...
A review of the scientific evidence for over-the-counter herbal remedies that are often used to combat sleep disorders such as insomnia has revealed that ‘surprisingly’ little research backs up their safety and efficacy.
Having been in the spotlight over skin health claims made, Swiss company Nutrilinks has now seen two of its claims regarding hair loss reduction and hair strength reinforcement rejected by the European Food Safety Authority (EFSA).
Royal DSM has emphasised “business continuity” and “smooth integration” following the completion of its $CAD540m (€436m) buy-out of the world’s largest omega-3 fish oil supplier, Ocean Nutrition Canada (ONC), today.
AarhusKarlshamn (AAK) has recorded strong second quarter (Q2) results driven by volume growth in its ingredients segment.
High consumption of vitamin E either from diet or vitamin supplements may lower the risk of liver cancer, according to new research.
EFSA health claim
Barry Callebaut has received a positive opinion from the European Food Safety Authority (EFSA) for a health claim linking cocoa to improved blood flow in news that has been welcomed by the broader confectionery industry.
Two months after Abbott Nutrition described brain food research as “one of our top global priorities”, Nestlé Health Science has acquired a stake in Accera, the US firm behind Axona, a medical food targeted at people with mild to moderate Alzheimer’s.